Jason Gerberry

Stock Analyst at B of A Securities

(3.42)
# 892
Out of 4,842 analysts
160
Total ratings
52.63%
Success rate
1.34%
Average return

Stocks Rated by Jason Gerberry

Teva Pharmaceutical Industries
May 8, 2025
Maintains: Buy
Price Target: $20$22
Current: $17.71
Upside: +24.22%
Vaxcyte
Apr 1, 2025
Maintains: Buy
Price Target: $157$137
Current: $31.73
Upside: +331.77%
Immunovant
Mar 20, 2025
Maintains: Buy
Price Target: $38$33
Current: $14.29
Upside: +130.93%
Viatris
Feb 28, 2025
Maintains: Underperform
Price Target: $11$10
Current: $8.60
Upside: +16.28%
Axsome Therapeutics
Feb 11, 2025
Maintains: Buy
Price Target: $143$167
Current: $103.98
Upside: +60.61%
Catalyst Pharmaceuticals
Jan 9, 2025
Reiterates: Buy
Price Target: $30
Current: $24.84
Upside: +20.77%
Exelixis
Dec 17, 2024
Downgrades: Neutral
Price Target: $35$39
Current: $43.09
Upside: -9.49%
bluebird bio
Nov 15, 2024
Downgrades: Neutral
Price Target: $60$10
Current: $5.00
Upside: +100.00%
Arcellx
Nov 6, 2024
Maintains: Buy
Price Target: $84$100
Current: $61.95
Upside: +61.42%
Biohaven
Sep 24, 2024
Maintains: Buy
Price Target: $52$62
Current: $15.34
Upside: +304.17%
Maintains: Buy
Price Target: $20$24
Current: $2.85
Upside: +742.11%
Maintains: Neutral
Price Target: $4$3
Current: $0.73
Upside: +310.96%
Maintains: Buy
Price Target: $67$68
Current: $33.32
Upside: +104.08%
Maintains: Buy
Price Target: $21$20
Current: $19.89
Upside: +0.55%
Downgrades: Underperform
Price Target: $41$31
Current: $28.97
Upside: +7.01%
Maintains: Buy
Price Target: $12$11
Current: $0.09
Upside: +12,428.47%
Maintains: Neutral
Price Target: $27$29
Current: $29.90
Upside: -2.99%
Maintains: Buy
Price Target: $29$37
Current: $15.37
Upside: +140.73%
Maintains: Buy
Price Target: $52$56
Current: $29.46
Upside: +90.09%
Downgrades: Underperform
Price Target: $30
Current: $33.76
Upside: -11.14%
Initiates: Neutral
Price Target: $63
Current: $25.54
Upside: +146.67%
Maintains: Buy
Price Target: $204$217
Current: $109.46
Upside: +98.25%
Downgrades: Underperform
Price Target: $4$2
Current: $0.32
Upside: +522.08%
Maintains: Buy
Price Target: $450$500
Current: $725.22
Upside: -31.06%
Downgrades: Underperform
Price Target: $9
Current: $1.08
Upside: +733.33%
Downgrades: Underperform
Price Target: $37$25
Current: $9.14
Upside: +173.52%
Downgrades: Underperform
Price Target: $45$5
Current: $1.70
Upside: +193.39%
Downgrades: Underperform
Price Target: $27
Current: $4.59
Upside: +488.24%
Initiates: Neutral
Price Target: $20
Current: $0.78
Upside: +2,466.41%
Downgrades: Neutral
Price Target: $17$10
Current: $0.57
Upside: +1,645.51%
Reinstates: Neutral
Price Target: $95
Current: $185.72
Upside: -48.85%
Reinstates: Buy
Price Target: $60
Current: $46.89
Upside: +27.96%
Reinstates: Neutral
Price Target: $37
Current: $23.61
Upside: +56.71%
Reinstates: Neutral
Price Target: $90
Current: $77.59
Upside: +15.99%